FEB 02, 2023
CMS Drug Rebate Policy Could Limit Innovation of Ophthalmic Drugs
The Academy presented at a stakeholder's event hosted by CMS on a new discarded drug refund plan in hopes of influencing Medicare drug policies to encourage innovation for ophthalmic drugs.